Literature DB >> 1102002

Principles of combination therapy.

S Levin, A A Harris.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1102002      PMCID： PMC1749606     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  102 in total

1.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

2.  In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice.

Authors:  M A Sande; J W Overton
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

3.  Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B.

Authors:  J J Rahal; M S Simberkoff; P J Hyams
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

4.  Modification of human neutrophil response to endotoxin with polymyxin B sulfate.

Authors:  J J Corrigan; O E Sieber; H Ratajczak; B B Bennett
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

5.  The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.

Authors:  S Greenfield; D S Feingold
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

6.  Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.

Authors:  J F Wallace; R H Smith; M Garcia; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1967-09

7.  Gram-negative rod bacteremia.

Authors:  C M Martin; A J Cuomo; M J Geraghty; J R Zager; T C Mandes
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

8.  Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.

Authors:  G L Wright; J Harper
Journal:  Lancet       Date:  1970-01-03       Impact factor: 79.321

9.  Resistance of Pseudomonas aeruginosa to carbenicillin.

Authors:  S M Bell; D D Smith
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

10.  Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation.

Authors:  M Finland; M C Bach; C Garner; O Gold
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191
View more
  6 in total

1.  In vitro synergism between carbenicillin and aminoglycosidic aminocyclitols against Acinetobacter calcoaceticus var. anitratus.

Authors:  R H Glew; R C Moellering; K R Buettner
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

Review 2.  Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy.

Authors:  Kishor C Mehta; Ramesh R Dargad; Dhammraj M Borade; Onkar C Swami
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 3.  Antifungal combination therapy: clinical potential.

Authors:  John W Baddley; Peter G Pappas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.

Authors:  Bijaya Sharma; Autumn V Brown; Nicole E Matluck; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

5.  Quantitation of antibiotics by high-pressure liquid chromatography: cephalothin.

Authors:  I Nilsson-Ehle; T T Yoshikawa; M C Schotz; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

6.  Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.

Authors:  Venkata Raveendra Pothineni; Hari-Hara S K Potula; Aditya Ambati; Venkata Vamsee Aditya Mallajosyula; Brindha Sridharan; Mohammed Inayathullah; Mohamed Sohail Ahmed; Jayakumar Rajadas
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.